Cognitive Enhancement Therapy for Alzheimerʼs Disease
- 1 May 1997
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 53 (5) , 752-768
- https://doi.org/10.2165/00003495-199753050-00003
Abstract
Although at present there is no definitive treatment or cure for Alzheimer’s disease, different pharmacological strategies are being actively investigated. At present, cholinergic therapy and...Keywords
This publication has 84 references indexed in Scilit:
- The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled TrialDementia and Geriatric Cognitive Disorders, 1996
- THE CLINICAL EPIDEMIOLOGY OF ALZHEIMER'S DISEASENeurologic Clinics, 1996
- In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neuronsFEBS Letters, 1995
- Cerebrospinal fluid levels of amyloid β‐protein in alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein e genotypeAnnals of Neurology, 1995
- Complement activation and β-amyloid-mediated neurotoxicity in Alzheimer's diseaseResearch in Immunology, 1992
- B- Amyloid increases neuronal susceptibility to injufy by glucose deprivationNeuroReport, 1991
- ESR spin trapping studies on the OH• free radical reactions of idebenoneArchives of Gerontology and Geriatrics, 1990
- Superoxide radical scavenging activity of idebenone in vitro studied by ESR spin trapping method and direct ESR measurement at liquid nitrogen temperatureArchives of Gerontology and Geriatrics, 1990
- Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's DiseaseNew England Journal of Medicine, 1990
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986